SRT3:XETRA Sartorius Aktiengesellschaft

EUR 356.10 -6.10 -1.684152
Icon

Sartorius Aktiengesellschaft (SRT3:XETRA) Stock Analysis and Price Targets

COMMON STOCK | Medical Instruments & Supplies | XETRA
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 356.10

-6.10 (-1.68)%

EUR 21.46B

0.07M

N/A

N/A

Icon

SRT3:XETRA

Sartorius Aktiengesellschaft (EUR)
COMMON STOCK | XETRA
EUR 356.10
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 21.46B

N/A

EUR 356.10

Sartorius Aktiengesellschaft (SRT3:XETRA) Stock Forecast

N/A

Based on the Sartorius Aktiengesellschaft stock forecast from 0 analysts, the average analyst target price for Sartorius Aktiengesellschaft is not available over the next 12 months. Sartorius Aktiengesellschaft’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Sartorius Aktiengesellschaft is Slightly Bearish, which is based on 7 positive signals and 10 negative signals. At the last closing, Sartorius Aktiengesellschaft’s stock price was EUR 356.10. Sartorius Aktiengesellschaft’s stock price has changed by -0.70% over the past week, +5.45% over the past month and -8.83% over the last year.

No recent analyst target price found for Sartorius Aktiengesellschaft
No recent average analyst rating found for Sartorius Aktiengesellschaft

Company Overview Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps ...Read More

https://www.sartorius.com

Otto-Brenner-Strasse 20, Göttingen, Germany, 37079

14,614

December

EUR

Germany

Adjusted Closing Price for Sartorius Aktiengesellschaft (SRT3:XETRA)

Loading...

Unadjusted Closing Price for Sartorius Aktiengesellschaft (SRT3:XETRA)

Loading...

Share Trading Volume for Sartorius Aktiengesellschaft Shares

Loading...

Compare Performance of Sartorius Aktiengesellschaft Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for SRT3:XETRA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Sartorius Aktiengesellschaft (Sector: Medical Instruments & Supplies )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CBHD:XETRA
Coloplast A/S -0.40 (-0.32%) EUR28.24B 41.84 3.91

ETFs Containing SRT3

Symbol Name SRT3's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Sartorius Aktiengesellschaft (SRT3:XETRA) Stock

Stock Target Advisor's fundamental analysis for Sartorius Aktiengesellschaft's stock is Slightly Bearish.

SRT3:XETRA stock's dividend yield is 0.21%. Our analysis grades SRT3:XETRA stock's dividend yield at F. This means that SRT3:XETRA stock's dividend yield is above 17% of the stocks in the Medical Instruments & Supplies sector in the XETRA exchange. Based on this SRT3:XETRA may be a poor dividend stock for its sector.

Unfortunately we do not have enough data on SRT3:XETRA's stock to indicate what its average analyst target is.

SRT3:XETRA stock's Price/Earning ratio is 117.63. Our analysis grades SRT3:XETRA stock's Price / Earning ratio at F. This means that SRT3:XETRA stock's Price/Earning ratio is above 86% of the stocks in the Medical Instruments & Supplies sector in the XETRA exchange. Based on this SRT3:XETRA may be a overvalued for its sector.

The last closing price of SRT3:XETRA's stock was EUR 356.10.

The most recent market capitalization for SRT3:XETRA is EUR 21.46B.

Unfortunately we do not have enough analyst data on SRT3:XETRA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Sartorius Aktiengesellschaft's stock.

As per our most recent records Sartorius Aktiengesellschaft has 14,614 Employees.

Sartorius Aktiengesellschaft's registered address is Otto-Brenner-Strasse 20, Göttingen, Germany, 37079. You can get more information about it from Sartorius Aktiengesellschaft's website at https://www.sartorius.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...